Viridian Therapeutics, Inc. VRDN Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s software and technology licenses, net?
- Viridian Therapeutics, Inc. (VRDN) reported software and technology licenses, net of $888K in Q1 2026.
- How has Viridian Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Viridian Therapeutics, Inc.'s software and technology licenses, net increased by 81.6% year-over-year, from $489K to $888K.
- What is the long-term trend for Viridian Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s software and technology licenses, net has grown at a 333.8% compound annual growth rate (CAGR), from $1K to $1.54M.